Our Partners
Building Governed AI Factories for Pharma
Pharma organisations in general are experimenting with AI across the business to drive innovation. Boston have delivered NVIDIA based solutions to support HCP’s need to leverage AI to turbocharge their research and extract information from their data. Boston is here to outline how marketing departments can take advantage of these technologies to optimise its messaging to HCP’s using business ready AI environments powered by NVIDIA AI Enterprise.
The real challenge isn’t AI itself. It’s deploying it reliably across your organisation.
Many teams face the same barriers. Balancing data security, access, and trust. Adhering to evolving regulatory requirements (EU AI Act, FDA guidance). How to measure ROI. Movement from isolated application-based trials to complex workflows that work at scale.
Boston Labs, our dedicated innovation and testing environment, allows exploration of NVIDIA-powered solutions, allows validation against regulatory requirements, and allows delivery into production with confidence.
What you’ll see on our stand:
- AI Agents for Pharma: Specialised agents that help teams find information faster, reduce manual effort and improve consistency in content creation, knowledge discovery and workflow automation. We’ll discuss how to design agents curated with your data while maintaining security.
- Omnichannel HCP Engagement: How NVIDIA technology can be used to deliver a consistent message to HCP’s, sales reps, email campaigns, website, seminar content and other channels.
- NVIDIA SPARK: A mini AI Factory that is a practical way to start your journey while being able to leverage NVIDIA’s vast ecosystem of tools.
- Governance that enables, not constrains: We can discuss how both Boston and other organisations have met the need to maintain security while adhering to regulatory requirements.
- How to access data: Techniques that should be used to access and curate your data ready to be used by AI.
For organisations just starting their AI journey:
Our Boston Future State AI Assessment evaluates your current readiness, identifies your highest-value opportunities, and builds a roadmap that connects AI investment directly to measurable business outcomes.
Come talk to us about:
Sovereign AI architectures | AI factories and scaling | Token economics and cost | Agentic workflows | Governance and compliance | Moving from experimentation to production
Boston Limited helps pharma deploy AI that is secure, scalable, trusted, and ready for real-world use.
Closing the Knowledge-to-Action Gap: How Cerebria Brain Is Shaping the Future of Medical Learning, Marketing, and Field Readiness
Cerebria.ai is an innovative medical artificial intelligence company transforming how pharmaceutical and healthcare organisations unlock, use, and scale knowledge across the enterprise. Built on the insight that critical expertise is often trapped within vast volumes of underutilised medical content, Cerebria converts existing materials – including clinical data, training assets, and scientific resources – into dynamic, interactive intelligence.
At the core of its offering is Cerebria Brain, an AI‑native, medical‑grade large language model platform that enables users to “ask” their organisation’s content and receive instant, context‑rich answers in over 100 languages. This capability transforms passive information into active engagement, supporting faster learning, improved retention, and more effective omnichannel communication across global teams.
Designed to meet the regulatory and scientific demands of the life sciences sector, Cerebria integrates seamlessly into existing systems, enabling scalable, personalised learning and knowledge delivery. Its advanced machine learning capabilities also support predictive insights, helping organisations enhance decision‑making, improve field readiness, and drive better patient and commercial outcomes.
Cerebria.ai’s mission is to accelerate knowledge transfer and empower organisations with intelligent, adaptive tools that elevate performance in an increasingly complex, data‑driven healthcare landscape.
Digital Peloton unites AI, data, and pharma media expertise to power the next generation of marketing. Our DP Factori tools deliver predictive planning, omnichannel activation, and performance insights—with full control and compliance at global scale.
Your global Intelligent Commercialization™ partner.
We provide tailored, innovative solutions to help health and life sciences companies by connecting data, technology, and AI with expert insight to drive faster, smarter decision-making at every stage of the commercialization journey.
Leveraging our connected capabilities, our experts guide you through each pivotal moment in your asset’s lifecycle – simplifying the complex, unlocking value, and enhancing treatment outcomes and patient access.
LEAP is a creative studio with global reach, crafting strategic, human-centered solutions. Our mastery lies in shaping the way people engage with content through the fusion of creativity, technology and design, pushing the boundaries of what’s possible.
For two decades, we’ve partnered with global pharmaceutical partners to transform complex scientific and medical information into engaging digital experiences. From HCP engagement, disease awareness and training to congress activations, internal communications and medical education, our projects bring greater impact, clarity and engagement to medical scientific communication.
Combining creativity with emerging technologies, we design and deliver interactive experiences, engaging activations and immersive simulations tailored to each strategic communication. Our multidisciplinary team creates solutions that make complex ideas and messages easier to understand, encourage meaningful engagement and bring data to life. Ultimately, everything we create is designed to transform complexity into clarity through experiences that inform, engage and create awareness.
Medisights is a frontier technology startup purpose-built for compliant life sciences insights at scale. Our AI-moderators aim to restore the qualitative depth in HCP interactions, which is then captured to build Digital Doctor Twins – pharma commercial teams can use these to actively “talk” to the data, test messaging and identify unmet needs. As a result, Medisights is actively reimagining a world beyond static insights stuck in PDFs.
Shaman is the leading no-code, do-it-yourself content authoring platform for Veeva Commercial Cloud, purpose-built for life sciences. Trusted by more than 3,000 marketing and medical content professionals across organisations including AstraZeneca, GSK, Novartis, Takeda, and Chiesi, Shaman enables teams to create, localise, reuse, and activate compliant multichannel content—from interactive CLM presentations and approved emails to landing pages and modular content—without design or coding skills.
Headquartered in Haarlem, the Netherlands, with employees in more than ten countries, Shaman is a certified Veeva Silver Product Partner and a recognised Veeva Content and AI Partner. The platform integrates natively with Veeva Vault PromoMats, keeping it as the single source of truth and ensuring compliance by design across every channel and market.
AI sits at the heart of Shaman’s approach to content excellence—embedded directly into authoring workflows to support teams rather than replace human judgment. Capabilities include MLR pre-checks, AI-assisted content comparison, intelligent reference checks, and AI-supported translation for global-to-local adaptation. Shaman’s next-generation solution, Aurora, brings together a team of specialised AI agents that co-create compliant, personalised emails through chat—turning campaign briefs into on-brand, MLR-ready drafts in minutes, with fewer review iterations and greater confidence from first submission.
The result is measurable impact at scale: customers report up to 80% reductions in time-to-market, significantly lower agency dependency, and stronger local adoption—bridging the gap between global strategy and local execution while keeping every asset compliant. More than a platform, Shaman is a strategic partner helping life sciences organisations transform how content is produced, governed, and brought to market.